Allergy expertise Capitalize on Bencard Allergie GmbH's deep 85 year+ heritage in allergy research to position advanced adjuvant and diagnostic solutions, and explore co development of perennial allergy therapies with Allergy Therapeutics.

Integrated diagnostics Offer expanded prick test solutions and molecular allergen characterization capabilities to strengthen their diagnostic portfolio and create cross selling opportunities with their existing products.

Innovative adjuvants Propose partnerships around novel adjuvants such as Virus-like-Particles and Bencard Adjuvant Systems to enhance vaccine or therapeutic efficacy for perennial allergies.

Regional expansion Target growth in Germany and Austria leveraging local market knowledge, regulatory familiarity, and the parent company’s international backing to accelerate market share in the regional allergy therapies space.

Digital and data Leverage their tech stack and analytics tools to propose precision marketing, outcome tracking, and post marketing surveillance collaborations that improve customer insights and demonstrate value to healthcare providers.